Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2026)

Regeneron Pharmaceuticals' Shares Repurchased history runs 9 years deep, the most recent figure standing at $794.3 million for Q1 2026.

• In Q1 2026, Shares Repurchased fell 23.73% year-over-year to $794.3 million; the TTM figure through Mar 2026 stood at $3.2 billion (down 4.83% YoY), while the FY2025 annual figure was $3.4 billion, up 32.09% from the prior year.
• Shares Repurchased was $794.3 million for Q1 2026 at Regeneron Pharmaceuticals, up from $671.7 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $1.1 billion in Q2 2025 to a low of $289.0 million in Q4 2023.
• Historically, Shares Repurchased has averaged $656.1 million across 5 years, with a median of $671.7 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Shares Repurchased jumped 461.66% in 2022, then slumped 59.01% in 2024.
• A 5-year view of Shares Repurchased shows it stood at $431.1 million in 2022, then tumbled by 32.96% to $289.0 million in 2023, then jumped by 236.68% to $973.0 million in 2024, then slumped by 30.97% to $671.7 million in 2025, then rose by 18.25% to $794.3 million in 2026.
• The last three Shares Repurchased figures came in at $794.3 million (Q1 2026), $671.7 million (Q4 2025), and $664.0 million (Q3 2025), per Business Quant data.